Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

By T. Gilmer, Christian R. Dolder, J. Lacro, D. Folsom, L. Lindamer, P. Garcia, Dilip Jeste. American Journal of Psychiatry, 2004

630 citations recorded by the source corpus.

Subfields: Clinical Psychology, Family Practice, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/ad3eb433b4833205d8b0b54ed48a38080c079866

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Fernandez‐Llimos
2. V. García-Cárdenas
3. Charlie Benrimoj
4. R. Cutler
5. M. Frommer

Citations in the corpus

• Economic impact of medication non-adherence by disease groups: a systematic review (2018, background): “65 81 98 Six studies used adjusted costs, finding that the total annual cost of non-adherence per patient ranged from $3252 to $19 363.(23) 25 58 59 72 90 Bagalman et al(25) focused primarily on”